FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL

K Number: K974261 · Decision Dec 11, 1997
Classifications
1
FEI Numbers
2
Registration Numbers
2
Same Product Code
5
Applicant Total
12
Review Days
28

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL
K Number
K974261
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.3780
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Boston Biomedica, Inc.
Date Received
November 13, 1997
Decision Date
December 11, 1997
Product Code
LJK
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LJK Antisera, If, Toxoplasma Gondii

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LJK), ordered by most recent decision date.

View all

Other Clearances by Boston Biomedica, Inc.

K Number Device Name
K032713 BOSTON BIOMEDICA, INC. BORRELIA BURGDORFERI IGM AND IGG
K980351 BBI-BIOTECH RESEARCH LABORATORIES B. BURGDORFERI IGM WESTERN BLOT KIT
K974811 ACCURUN(TM) 150 HSV IGG POSITIVE CONTROL
K974809 ACCURUN(TM) 130 BORRELIA BURGDORFERI IGG POSITIVE CONTROL
K974810 ACCURUN(TM) 132 BORRELIA BURDORFERI IGM POSITIVE CONTROL
K972986 ACCURUN 140 RUBELLA IGG POSITIVE CONTROL
K972884 ACCURUN 146 CMV IGM POSITIVE CONTROL
K971657 ACCURUN 121 HAV IGM POSITIVE CONTROL
K972048 ACCURUN 117 HBEAG POSITIVE CONTROL
K972307 ACCURUN 119 ANTI-HEPATITIS B E ANTIGEN (ANTI-HBE) POSITIVE CONTROL
Search all 12 clearances from Boston Biomedica, Inc. →